916319-64-7Relevant articles and documents
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
-
Page/Page column 36, (2010/11/25)
Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KSS) are disclosed,